ADO 8.33% 2.2¢ anteotech ltd

was looking thru more of the reports from market merger of late....

  1. 658 Posts.
    was looking thru more of the reports from market merger of late.

    their team of researchers are credible and provide insights to e big big deals. they are selective in their research, putting down 3-10 potential takeover targets in each issue.


    e list of bidders are star studded, really, all 7 of them.

    1. Thermo Fisher Scientific Inc
    - world leading in serving science
    - $10 billion annual revenues
    -list of acquisitions from http://ir.thermofisher.com/phoenix.zhtml?c=89145&p=irol-newsMerger&nyo=1

    7 deals from jan - dec 2010
    2 of these deals, Fermantas and Finnzymes are kinda towards the diagnostics aspect (ie Thermo Fisher Scientific's Analytical Technologies Segment).


    2. Roche Holding Ltd
    - world leader in health care(pharmaceutical and diagnostics)
    - $49 billon annual revenues
    - Nov 22, 2010
    Swiss drug maker Roche (VTX:ROG) is exploring potential acquisitions despite its current focus on cost savings, CEO Severin Schwan told Swiss weekly SonntagsZeitung. According to the chief executive, the company is primarily looking at smaller to mid-sized acquisitions or partnerships that would help it improve its profitability. Roche is slashing 4,800 jobs worldwide as part of its operational excellence programme. Country: , Switzerland Sector: Pharmaceuticals Target: Small to mid-sized companies Buyer: Roche Holding Ltd Type: Corporate acquisition Status: Bidding Comment: Roche's CEO says company would pursue acquisitions.

    http://www.tradingmarkets.com/news/stock-alert/rhhzy_swiss-roche-on-the-hunt-for-acquisitions-1323445.html

    well doesnt ADO fit into that?


    Life Technologies Corp
    - global biotech coy built up with all its acquisitions
    - $3 plus billion
    - as we know it, Life tech thru Invitrogen is partnering ADO with development of a diagnostic assay

    4 Merck & Co Inc
    - major pharmaceutical
    - $40 billion
    - Merck has already signed a licensing agreement with ADO.
    - Merck made a mammoth acquisition last year (Millipore) which allowed it to double its revenue.

    will post more about the following 3 later and more.
    Abbott Laboratories
    Beckman Coulter Inc
    Siemens Healthcare Diagnostics limited



 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
-0.002(8.33%)
Mkt cap ! $54.31M
Open High Low Value Volume
2.4¢ 2.4¢ 2.2¢ $40.20K 1.786M

Buyers (Bids)

No. Vol. Price($)
2 386453 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 248196 1
View Market Depth
Last trade - 16.10pm 03/09/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.